| 1 |
Franco PIR, Neto JRDC, de Menezes LB, Machado JR, Miguel MP. Revisiting the hallmarks of cancer: A new look at long noncoding RNAs in breast cancer. Pathol Res Pract 2023;243:154381. [PMID: 36857948 DOI: 10.1016/j.prp.2023.154381] [Reference Citation Analysis]
|
| 2 |
Zhai J, Han J, Li C, Lv D, Ma F, Xu B. Tumor senescence leads to poor survival and therapeutic resistance in human breast cancer. Front Oncol 2023;13:1097513. [PMID: 36937388 DOI: 10.3389/fonc.2023.1097513] [Reference Citation Analysis]
|
| 3 |
Chen J, Li X, Yan S, Li J, Zhou Y, Wu M, Ding J, Yang J, Yuan Y, Zhu Y, Wu W. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer. Front Oncol 2022;12:929240. [PMID: 36591508 DOI: 10.3389/fonc.2022.929240] [Reference Citation Analysis]
|
| 4 |
Cao J, Liang Y, Gu JJ, Huang Y, Wang B. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.991162] [Reference Citation Analysis]
|
| 5 |
Gao S, Wu X, Lou X, Cui W. Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer. Front Genet 2022;13:960567. [DOI: 10.3389/fgene.2022.960567] [Reference Citation Analysis]
|
| 6 |
Jiang B, Zhu H, Feng W, Wan Z, Qi X, He R, Xie L, Li Y. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Dis Markers 2022;2022:9004830. [PMID: 36312586 DOI: 10.1155/2022/9004830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Wang Z, Yao J, Dong T, Niu X. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma. J Immunol Res 2022;2022:2756611. [PMID: 36281357 DOI: 10.1155/2022/2756611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Cao J, Xu Y, Liu X, Cai Y, Luo B. Innovative signature establishment using lymphangiogenesis-related lncRNA pairs to predict prognosis of hepatocellular carcinoma. Heliyon 2022;8:e10215. [PMID: 36033263 DOI: 10.1016/j.heliyon.2022.e10215] [Reference Citation Analysis]
|
| 9 |
Xu Y, Chen Y, Niu Z, Yang Z, Xing J, Yin X, Guo L, Zhang Q, Yang Y, Han Y. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.860806] [Reference Citation Analysis]
|
| 10 |
Sobhani N, Chahwan R, Roudi R, Morris R, Volinia S, Chai D, D'Angelo A, Generali D. Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. Cancers (Basel) 2022;14:2952. [PMID: 35740618 DOI: 10.3390/cancers14122952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Yang Y, Liu H, Liu Y. A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer. Front Genet 2022;13:912125. [DOI: 10.3389/fgene.2022.912125] [Reference Citation Analysis]
|
| 12 |
Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Zhu K, Liu X, Deng W, Wang G, Fu B. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer. Hereditas 2022;159. [DOI: 10.1186/s41065-021-00212-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 14 |
Xu M, Zhang R, Qiu J. A four immune-related long noncoding RNAs signature as predictors for cervical cancer. Hum Cell 2021. [PMID: 34846702 DOI: 10.1007/s13577-021-00654-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Izadi M, Ali TA, Pourkarimi E. Over Fifty Years of Life, Death, and Cannibalism: A Historical Recollection of Apoptosis and Autophagy. Int J Mol Sci 2021;22:12466. [PMID: 34830349 DOI: 10.3390/ijms222212466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y, He X, Ren Y, Wu Y, Zhang Q. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer. Front Oncol 2021;11:745719. [PMID: 34722303 DOI: 10.3389/fonc.2021.745719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Liang J, Zhang L, Cheng W. Non-coding RNA-mediated autophagy in cancer: A protumor or antitumor factor? Biochim Biophys Acta Rev Cancer 2021;1876:188642. [PMID: 34715268 DOI: 10.1016/j.bbcan.2021.188642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 18 |
Xu Z, Jiang S, Ma J, Tang D, Yan C, Fang K. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment. Front Surg 2021;8:742360. [PMID: 34671639 DOI: 10.3389/fsurg.2021.742360] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Wang X, Chen K, Wang Z, Xu Y, Dai L, Bai T, Chen B, Yang W, Chen W. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer. Front Cell Dev Biol 2021;9:750709. [PMID: 34660608 DOI: 10.3389/fcell.2021.750709] [Reference Citation Analysis]
|
| 20 |
Lv W, Tan Y, Zhao C, Wang Y, Wu M, Wu Y, Ren Y, Zhang Q. Identification of pyroptosis-related lncRNAs for constructing a prognostic model and their correlation with immune infiltration in breast cancer. J Cell Mol Med 2021;25:10403-17. [PMID: 34632690 DOI: 10.1111/jcmm.16969] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 21 |
Zheng Z, Wu W, Lin Z, Liu S, Chen Q, Jiang X, Xue Y, Lin D. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. BMC Med Genomics 2021;14:236. [PMID: 34579730 DOI: 10.1186/s12920-021-01085-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Gao L, Li Q. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis. Cancer Manag Res 2021;13:7175-86. [PMID: 34552353 DOI: 10.2147/CMAR.S325710] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 23 |
Zampedri C, Martínez-Flores WA, Melendez-Zajgla J. The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer. Front Oncol 2021;11:687594. [PMID: 34123857 DOI: 10.3389/fonc.2021.687594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Wu Q, Li Q, Zhu W, Zhang X, Li H. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer. J Cell Mol Med 2021;25:4088-98. [PMID: 33694315 DOI: 10.1111/jcmm.16378] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
|
